Hypothalamic obesity is a complex condition. Dietary changes won’t likely result in lasting weight loss, but there are other benefits for long-term health. The hypothalamus is a small but important ...
Bivamelagon showed significant BMI reductions in hypothalamic obesity patients, prompting Rhythm Pharmaceuticals to seek FDA guidance for Phase 3 trials. Rhythm Pharmaceuticals, Inc. announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results